Clinical Trials Browser

Not yet recruiting × Esophageal Squamous Cell Carcinoma × Injections × Clear all

NCT06508229 2024-07-18

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma